Harvard Medical School Researcher Wins 2024 Lasker Award for Work That Led to GLP-1 Therapies
Joel Habener, fellow scientists honored for discoveries paving the way to GLP-1 based treatments
Studies Deepen Understanding of LGBTQ Health Disparities
Researchers point to solutions and opportunities for better health
Training Inventors of Future Medicines
New educational opportunities immerse HMS students in drug discovery and development
A New Artificial Intelligence Tool for Cancer
ChatGPT-like AI model can diagnose, guide treatment, predict survival for multiple cancer types
Deadly Eastern Equine Encephalitis Virus Is a Familiar but Formidable Foe
Harvard Medical School expert discusses challenges of diagnosis, treatment, and what lies ahead
What Enables Herpes Simplex Virus To Become Impervious to Drugs?
Findings about how cold sore virus evades treatment offer broader clues on drug resistance
How Thyroid Hormone Fuels the Drive to Explore
Research in mice reveals role for hormone in altering brain wiring to shape behavior
Mpox Declared Public Health Emergency of International Concern. Now What?
Making sense of the latest developments with HMS infectious disease specialist Daniel Kuritzkes
New AI Tool Captures How Proteins Behave in Context
PINNACLE predicts protein functions in cells and tissues, can help improve drug discovery
The Risks of Artificial Intelligence in Weapons Design
Researchers outline dangers of developing AI-powered autonomous weapons
Which Strains of Tuberculosis Are the Most Infectious?
Shared geographic origin between TB strain and human host could amplify risk for infection
What Will the New Cardiovascular Risk Calculator Mean for Patients?
Analysis forecasts more heart attacks and strokes as fewer people become eligible for meds